MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/190/0.1/20.09.24 | Market Closed - Börse Stuttgart 17:50:29 28/06/2024 BST | ||
| 0.065 EUR | -2.99% |
|
| Current month | +25.00% | ||
| 1 month | +32.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 0.065 | -2.99% |
| 27/06/24 | 0.067 | -5.63% |
| 26/06/24 | 0.071 | -19.32% |
| 25/06/24 | 0.088 | +44.26% |
| 24/06/24 | 0.061 | -4.69% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 05:50 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Morgan Stanley |
| WKN | ME9ZMT |
| ISIN | DE000ME9ZMT2 |
| Date issued | 11/03/2024 |
| Strike | 190 $ |
| Maturity | 20/09/2024 (83 Days) |
| Parity | 10 : 1 |
| Emission price | 0.31 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.216 € |
|---|---|
| Lowest since issue | 0.031 € |
| Delta | 0.07x |
| Omega | 14.13 |
| Premium | 33.58x |
| Gearing | 211.54x |
| Moneyness | 0.7513 |
| Difference Strike | 47.26 $ |
| Difference Strike % | +24.87% |
| Spread | 0.006 € |
| Spread % | 9.09% |
| Theoretical value | 0.0630 |
| Implied Volatility | 35.96 % |
| Total Loss Probability | 95.29 % |
| Intrinsic value | 0.000000 |
| Present value | 0.0630 |
| Break even | 190.67 € |
| Theta | -0.01x |
| Vega | 0.01x |
| Rho | 0x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006
DKK
Average target price
949.7
DKK
Spread / Average Target
-5.56%
- Stock Market
- Warrants
- Warrant
